Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis
Guardado en:
Autores principales: | Jie Dong, Qiong Zhou, Qingqing Sun, Nannan Lu, Yueyin Pan, Xinghua Han |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c240183e3d544c0d86de99df8b0e9aa6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
por: M. Liontos, et al.
Publicado: (2021) -
Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients
por: Jiujun Zhu, et al.
Publicado: (2021) -
Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
por: Ziyi Liu, et al.
Publicado: (2021) -
The prognostic value of neutrophil-lymphocyte ratio in acute pancreatitis
por: Binit Katuwal, et al.
Publicado: (2016) -
Prognostic value of the neutrophil-to-lymphocyte ratio in acute organophosphorus pesticide poisoning
por: Mu Yuhang, et al.
Publicado: (2021)